Matches in Wikidata for { <http://www.wikidata.org/entity/Q88633485> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q88633485 description "article scientifique publié en 2018" @default.
- Q88633485 description "artículu científicu espublizáu en mayu de 2018" @default.
- Q88633485 description "im Mai 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q88633485 description "scientific article published on 01 May 2018" @default.
- Q88633485 description "wetenschappelijk artikel" @default.
- Q88633485 description "наукова стаття, опублікована в травні 2018" @default.
- Q88633485 name "Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction)" @default.
- Q88633485 name "Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction)" @default.
- Q88633485 type Item @default.
- Q88633485 label "Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction)" @default.
- Q88633485 label "Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction)" @default.
- Q88633485 prefLabel "Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction)" @default.
- Q88633485 prefLabel "Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction)" @default.
- Q88633485 P1433 Q88633485-460C9749-53E3-4980-B8D8-A219AE3F5A6C @default.
- Q88633485 P1476 Q88633485-6A5CBC08-D418-4A9E-83A2-98A8A252A416 @default.
- Q88633485 P2093 Q88633485-00C67834-EA4E-4F96-9E0C-A103CAD0723C @default.
- Q88633485 P2093 Q88633485-1C6FCFF3-B760-4ECB-9A71-D77D245CAE6D @default.
- Q88633485 P2093 Q88633485-20F81CAA-9343-4B5F-90FF-536C0E836916 @default.
- Q88633485 P2093 Q88633485-37A9CA5F-DEA3-4856-85C2-5C21169A4CA0 @default.
- Q88633485 P2093 Q88633485-7D9FDC53-FE9A-4C66-9F34-17567344B8F7 @default.
- Q88633485 P2093 Q88633485-CBF9AD83-D37D-40E8-A814-505C4DDFD22F @default.
- Q88633485 P2093 Q88633485-E6C236FF-F703-4A12-A662-25F272C491D8 @default.
- Q88633485 P2093 Q88633485-E71A43CC-13A6-441A-AC89-A3820660703C @default.
- Q88633485 P2093 Q88633485-EE549941-3CEC-4EC4-BEB4-9B2562D66AD7 @default.
- Q88633485 P304 Q88633485-163D0822-29F6-4D27-BD2F-EB69DE7CFB1C @default.
- Q88633485 P31 Q88633485-9AF645D1-2CEB-4A59-AE13-C4B1984BAB56 @default.
- Q88633485 P356 Q88633485-96F44761-2F03-41C7-A939-58E2EDF3F5F3 @default.
- Q88633485 P433 Q88633485-29C9AAD7-1ECF-44CF-9B03-C3B07FEABADD @default.
- Q88633485 P478 Q88633485-C3E5D0E9-A56D-41C4-8C33-6A4FE0620938 @default.
- Q88633485 P50 Q88633485-1D864481-EE7A-4289-BD6D-C27008269035 @default.
- Q88633485 P50 Q88633485-397A1976-64AF-4754-B16D-69EE607BD103 @default.
- Q88633485 P577 Q88633485-AA17CDEA-BEDF-4ED9-AB78-B6D8AEA08F59 @default.
- Q88633485 P698 Q88633485-9FEE858B-A7B3-4315-A6E6-2C8A8C74596C @default.
- Q88633485 P921 Q88633485-0468E6E8-989C-4A35-87D0-02E8BBE1C0E5 @default.
- Q88633485 P921 Q88633485-12AAD6B3-DA07-44C2-926B-DC6E4F4A98AF @default.
- Q88633485 P921 Q88633485-6939BC47-BB32-48C6-84DA-DE09B0D30E2D @default.
- Q88633485 P921 Q88633485-817EBAB1-603B-44E1-8330-68FE53928B0E @default.
- Q88633485 P356 CIRCOUTCOMES.117.003998 @default.
- Q88633485 P698 29748353 @default.
- Q88633485 P1433 Q15816436 @default.
- Q88633485 P1476 "Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction)" @default.
- Q88633485 P2093 "Christian T Ruff" @default.
- Q88633485 P2093 "Eugene Braunwald" @default.
- Q88633485 P2093 "Francesco Nordio" @default.
- Q88633485 P2093 "James Aisenberg" @default.
- Q88633485 P2093 "Kathryn Friedman Flack" @default.
- Q88633485 P2093 "Michele F Mercuri" @default.
- Q88633485 P2093 "Prapti Chatterjee-Murphy" @default.
- Q88633485 P2093 "Robert P Giugliano" @default.
- Q88633485 P2093 "Youngsook Choi" @default.
- Q88633485 P304 "e003998" @default.
- Q88633485 P31 Q13442814 @default.
- Q88633485 P356 "10.1161/CIRCOUTCOMES.117.003998" @default.
- Q88633485 P433 "5" @default.
- Q88633485 P478 "11" @default.
- Q88633485 P50 Q29561411 @default.
- Q88633485 P50 Q64496972 @default.
- Q88633485 P577 "2018-05-01T00:00:00Z" @default.
- Q88633485 P698 "29748353" @default.
- Q88633485 P921 Q1931577 @default.
- Q88633485 P921 Q407431 @default.
- Q88633485 P921 Q63279445 @default.
- Q88633485 P921 Q815819 @default.